However, the $9 billion valuation feels bubblish. Consider that Quest and Labcorp are both $10 billion companies, and Theranos is talking about driving down the price of testing. They need a lot of elasticity in this market to make the numbers work out.
Throw in some more specific stuff, it goes up to $1500 or so. I have a medical condition that requires a blood test every 4 months in that price range. Thankfully insurance covers it, but checking one box on the list of things to test increases the price 800% for reasons that I don't understand.
But with lab-on-chip having moore's law like economics, won't competition come sooner or later, and crush the market?
One employee listed and a whopping sized board of directors, most of which come from the government or the military. Smells like something straight from the military industrial complex.
Classic rookie copywriter mistake.